Encompass Health Corporation EHC Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Net margin | 9.5%+1.1pp | 8.5%+1.1pp | 7.3%+1.1pp | 6.2%-4.0pp | |
| Returns | |||||
| Return on equity | 25.1%+0.6pp | 24.5%+0.7pp | 23.8%+7.0pp | 16.8%-6.7pp | |
| Return on invested capital | 16.3%+2.1pp | 14.2%+1.9pp | 12.4%+4.3pp | 8.1%-0.3pp | |
| Efficiency | |||||
| Asset turnover | 0.9×0.0× | 0.9×0.0× | 0.8×+0.1× | 0.7×+0.1× | |
| Liquidity | |||||
| Current ratio | 1.1×0.0× | 1.1×-0.2× | 1.3×0.0× | 1.2×0.0× | |
| Leverage | |||||
| Debt-to-equity | 1.3×-0.3× | 1.5×-0.5× | 2×-0.6× | 2.6×+0.5× | |
| Net debt / EBITDA | 2.1×-0.5× | 2.6×-0.5× | 3.1×-1.1× | 4.2×-0.6× | |
| Per Share | |||||
| Book value per share | $23.86+18.0% | $20.23+24.4% | $16.26+24.6% | $13.05-31.6% | |
| Valuation | |||||
| Market capitalization | $10.68B+14.8% | $9.3B+40.2% | $6.64B+11.8% | $5.94B+15.4% | |
| Price / earnings | 18.9×-1.6× | 20.4×+1.6× | 18.9×-3.1× | 21.9×+9.4× | |
| Price / sales | 1.8×+0.1× | 1.7×+0.3× | 1.4×0.0× | 1.4×+0.1× | |
| Price / book | 4.4×-0.1× | 4.5×+0.5× | 4×-0.5× | 4.5×+1.8× | |
| EV / EBITDA | 9.7×-0.7× | 10.4×+0.8× | 9.6×-2.2× | 11.8×+0.6× | |
| Dividend yield | 0.7%0.0pp | 0.7%-0.2pp | 0.9%-0.8pp | 1.7%-0.5pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Encompass Health Corporation's ratios come from?
- Every ratio is computed from Encompass Health Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
